A gastrointestinal rotavirus infection mouse model for immune modulation studies

Virology Journal

Volumn 8, Issue , 2011, Pages

  Knipping, Karen ^a,d   McNeal, Monica M ^b   Crienen, Annelies ^a   Van Amerongen, Geert ^c   Garssen, Johan ^a,d   Van'T Land, Belinda ^a,d  

^a DANONE RESEARCH   (Netherlands)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c Dutch Vaccine Institute   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROGARD R; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DIARRHEA; EPIZOOTIC DIARRHEA INFANT MOUSE VIRUS; FECES ANALYSIS; FEMALE; GASTROINTESTINAL INFECTION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; INOCULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NEWBORN; NONHUMAN; REINFECTION; ROTAVIRUS; ROTAVIRUS INFECTION; SIMIAN ROTAVIRUS; SYMPTOM; T LYMPHOCYTE; TREATMENT DURATION; VIRUS; VIRUS LOAD; VIRUS SHEDDING; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DISEASE MODEL; GASTROINTESTINAL TRACT; HUMAN; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

MUS; RHESUS ROTAVIRUS; ROTAVIRUS;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; DIARRHEA; DISEASE MODELS, ANIMAL; GASTROINTESTINAL TRACT; HUMANS; MICE; MICE, INBRED BALB C; ROTAVIRUS; ROTAVIRUS INFECTIONS;

EID: 79952353840     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-109     Document Type: Article

References (32)

1. Rotavirus vaccines: an overview. PH Dennehy, Clin Microbiol Rev 2008 21 198 208 10.1128/CMR.00029-07 18202442 (Pubitemid 351160015)
2. Intussusception among infants given an oral rotavirus vaccine. TV Murphy PM Gargiullo MS Massoudi DB Nelson AO Jumaan CA Okoro LR Zanardi S Setia E Fair CW LeBaron, et al. N Engl J Med 2001 344 564 572 10.1056/NEJM200102223440804 11207352 (Pubitemid 32167870)
3. Immunity and correlates of protection for rotavirus vaccines. MA Franco J Angel HB Greenberg, Vaccine 2006 24 2718 2731 10.1016/j.vaccine.2005.12.048 16446014
4. Rotaviruses. AZ Kapikian Y Hoshino RM Chanock, Fields Virology 2001 2 1806
5. Virus-specific immunity in neonatal and adult mouse rotavirus infection. JF Sheridan RS Eydelloth SL Vonderfecht L Aurelian, Infect Immun 1983 39 917 927 6299952 (Pubitemid 13188376)
6. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. RL Ward, Viral Immunol 2003 16 17 24 10.1089/088282403763635410 12725685 (Pubitemid 36427736)
7. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. MA Franco HB Greenberg, J Virol 1995 69 7800 7806 7494291
8. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. N Feng JW Burns L Bracy HB Greenberg, J Virol 1994 68 7766 7773 7966566 (Pubitemid 24362663)
9. Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities. MM McNeal MN Rae RL Ward, J Virol 1997 71 8735 8742 9343232 (Pubitemid 27446456)
10. CD8+ T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice. MA Franco C Tin HB Greenberg, J Virol 1997 71 4165 4170 9094702 (Pubitemid 27172440)
11. Characterization of homologous and heterologous rotavirus-specific T-cell responses in infant and adult mice. MC Jaimes N Feng HB Greenberg, J Virol 2005 79 4568 4579 10.1128/JVI.79.8.4568-4579.2005 15795243 (Pubitemid 40464208)
12. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates. JL VanCott AE Prada MM McNeal SC Stone M Basu B Huffer Jr KL Smiley M Shao JA Bean JD Clements, et al. J Virol 2006 80 4949 4961 10.1128/JVI.80.10.4949-4961.2006 16641286
13. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. GP Davidson PB Whyte E Daniels K Franklin H Nunan PI McCloud AG Moore DJ Moore, Lancet 1989 2 709 712 10.1016/S0140-6736(89) 90771-X 2570959 (Pubitemid 19243115)
14. Neonatal adaptive immunity comes of age. B Adkins C Leclerc S Marshall-Clarke, Nat Rev Immunol 2004 4 553 564 10.1038/nri1394 15229474 (Pubitemid 38931770)
15. Immunity to rotavirus in T cell deficient mice. MA Franco HB Greenberg, Virology 1997 238 169 179 10.1006/viro.1997.8843 9400590 (Pubitemid 28218135)
16. Early response to rotavirus infection involves massive B cell activation. SE Blutt KL Warfield DE Lewis ME Conner, J Immunol 2002 168 5716 5721 12023371 (Pubitemid 34556155)
17. Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. T Dharakul L Rott HB Greenberg, J Virol 1990 64 4375 4382 1974652 (Pubitemid 20279848)
18. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. MM McNeal KS Barone MN Rae RL Ward, Virology 1995 214 387 397 10.1006/viro.1995.0048 8553539
19. Immunity to rotavirus infection in mice. MA Franco HB Greenberg, J Infect Dis 1999 179 Suppl 3 466 469 10.1086/314805 10099121
20. Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity. SE Blutt KL Warfield MK Estes ME Conner, J Virol 2008 82 3135 3138 10.1128/JVI.01727-07 18184712 (Pubitemid 351329202)
21. Recognition of rotavirus antigens by mouse L3T4-positive T helper cells. MG Bruce I Campbell Y Xiong M Redmond DR Snodgrass, J Gen Virol 1994 75 Pt 8 1859 1866 10.1099/0022-1317-75-8-1859 8046388 (Pubitemid 24243064)
22. The role of serum antibodies in the protection against rotavirus disease: an overview. B Jiang JR Gentsch RI Glass, Clin Infect Dis 2002 34 1351 1361 10.1086/340103 11981731 (Pubitemid 34507945)
23. Serum and intestinal immune response to rotavirus enteritis in children. GP Davidson RJ Hogg CP Kirubakaran, Infect Immun 1983 40 447 452 6301996 (Pubitemid 13133249)
24. Serologic and mucosal immune response to rotavirus infection in the rabbit model. ME Conner MA Gilger MK Estes DY Graham, J Virol 1991 65 2562 2571 1850029
25. IgG2a restriction of murine antibodies elicited by viral infections. JP Coutelier JT van der Logt FW Heessen G Warnier J Van Snick, J Exp Med 1987 165 64 69 10.1084/jem.165.1.64 3794607 (Pubitemid 17223672)
26. Virally induced modulation of murine IgG antibody subclasses. JP Coutelier JT van der Logt FW Heessen A Vink J van Snick, J Exp Med 1988 168 2373 2378 10.1084/jem.168.6.2373 3199074 (Pubitemid 19020914)
27. Passive immunity to bovine rotavirus infection associated with transfer of serum antibody into the intestinal lumen. TE Besser CC Gay TC McGuire JF Evermann, J Virol 1988 62 2238 2242 2836607
28. Survival of rotavirus antibody activity derived from bovine colostrum after passage through the human gastrointestinal tract. J Pacyna K Siwek SJ Terry ES Roberton RB Johnson GP Davidson, J Pediatr Gastroenterol Nutr 2001 32 162 167 10.1097/00005176-200102000-00013 11321386 (Pubitemid 32280630)
29. Inhibitory effects of human and bovine milk constituents on rotavirus infections. AS Kvistgaard LT Pallesen CF Arias S Lopez TE Petersen CW Heegaard JT Rasmussen, J Dairy Sci 2004 87 4088 4096 10.3168/jds.S0022-0302(04)73551-1 15545370 (Pubitemid 39606240)
30. Supplementing suckling rats with whey protein concentrate modulates the immune response and ameliorates rat rotavirus-induced diarrhea. FJ Perez-Cano S Marin-Gallen M Castell M Rodriguez-Palmero M Rivero C Castellote A Franch, J Nutr 2008 138 2392 2398 10.3945/jn.108.093856 19022963
31. Supplemental dietary whey protein concentrate reduces rotavirus-induced disease symptoms in suckling mice. FM Wolber AM Broomfield L Fray ML Cross D Dey, J Nutr 2005 135 1470 1474 15930454 (Pubitemid 40799612)
32. Epidemiology of rotavirus in infants and protection against symptomatic illness afforded by primary infection and vaccination. JZ Mrukowicz J Thompson GW Reed SJ Tollefson M Kobayashi K Araki PF Wright, Vaccine 1999 17 745 753 10.1016/S0264-410X(98)00258-8 10067679 (Pubitemid 29074727)